CytoMed Therapeutics Ltd

GDTC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001873093

SEC filings (opens in a new tab)

In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding CytoMed Therapeutics Ltd changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of GDTC: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Q2 2026	Change
Holders	3	3	0
Shares	16.3K	11.9K	−4.46K (−27.3%)
Value	$16.3K	$12.2K	−$4.10K (−25.1%)

New holders (1)

Institutions that held CytoMed Therapeutics Ltd at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to GDTC in Q2 2026
Institution	Shares	Value	% of portfolio
Axiom Investment Management LLC	7,032	$7.24K	0.00%

Sold out (1)

Institutions that held CytoMed Therapeutics Ltd at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of GDTC in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
XTX Topco Ltd	10,136	$10.1K